Clinical Trial: RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07816471) titled 'RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults' on Sept. 07.

Brief Summary: Respiratory syncytial virus (RSV), influenza, and SARS-CoV-2 are common respiratory viruses. In healthy adults they usually cause mild, cold-like illness, but in people whose immune system is severely weakened - such as people who have had a bone marrow, stem cell, or organ transplant, people being treated for cancer or blood disorders, or people taking medicines that suppress the immune system - these infections can be much more serious, sometimes spreading from the nose and throat down into the lungs and leading to hospitaliza...